Shanghai Yizhong
SSE · 688091
Market Cap$8.8B
Revenue$324.2M
Employees437
Listed OnSSE
Ticker688091
CEO / ExecMr. Jingsong Zhou
HeadquartersShanghai
MarketMainland China
Websitewww.yizhongpharma.com
Overview
Shanghai Yizhong Pharmaceutical Co., Ltd. engages in the development of anti-tumor drugs and related products in China. It also offers paclitaxel polymer nanomicelles for the treatment of non-small cell lung cancer, as well as various types of cancer, including esophageal cancer, gastric cancer, nasopharyngeal carcinoma, pancreatic cancer, breast cancer, gynecological tumors, etc. The company was founded in 2009 and is headquartered in Shanghai, China.
Data Note
This record combines exchange-directory fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.